New Release: Alpha testing version has been released.

Salicylic Acid

D07X - Corticosteroids, other combinations ATC D02AF Small molecule Natural product

JFDA label: VERRUMAL Solution

Indications

Approved

  • Acne Vulgaris — acne
  • Callosities — keratosis
  • Dandruff — dermatitis
  • Dermatitis, Seborrheic — seborrheic dermatitis
  • Eye Diseases — eye inflammation
  • Inflammation — inflammation
  • Pruritus — Pruritus
  • Psoriasis — psoriasis
  • Skin Diseases — skin disease
  • Skin Neoplasms — skin cancer
  • Sunburn — sunburn
  • Warts — common wart

Off-label

  • Acute Coronary Syndrome
  • Cardiovascular Diseases
  • Headache
  • Heavy Metal Poisoning
  • Hypercholesterolemia
  • Infertility
  • Keratosis
  • Keratosis, Actinic
  • Pharyngitis
  • Stroke
  • Tension-Type Headache
  • Thrombophilia
  • Thrombosis

Adverse Reactions

Very Common >10%Common 1–10%Uncommon 0.1–1% Rare 0.01–0.1%Very Rare <0.01%Not Known

Vascular disorders (1)

Not Known Ecchymosis

Nervous system disorders (3)

Not Known Dizziness · Headache · Somnolence

Hepatobiliary disorders (1)

Not Known Hepatitis

Gastrointestinal disorders (10)

Not Known Abdominal discomfort · Abdominal pain upper · Constipation · Decreased appetite · Diarrhoea · Duodenal ulcer · Dyspepsia · Nausea · Oesophagitis · Vomiting

Skin and subcutaneous tissue disorders (7)

Not Known Dermatitis · Erythema · Erythema multiforme · Pruritus · Rash · Skin exfoliation · Urticaria

Psychiatric disorders (2)

Not Known Confusional state · Hallucination

Ear and labyrinth disorders (3)

Not Known Deafness · Hearing impaired · Tinnitus

Investigations (2)

Not Known Feeling abnormal · Weight increased

General disorders and administration site conditions (8)

Not Known Burning sensation · Dysgeusia · Gastric ulcer · Lethargy · Occult blood positive · Oedema · Pain · Skin papilloma

Respiratory, thoracic and mediastinal disorders (2)

Not Known Asthma · Epistaxis

Dosing

Source: openFDA

Directions Cleanse the skin thoroughly before applying medication. Cover the entire affected area with a thin layer one to three times daily. Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor. If bothersome dryness or peeling occurs, reduce application to once a day or every other day. Sensitivity Test for a New User. Apply product sparingly to one or two small affected areas during the first 3 days. If no discomfort occurs, follow the directions stated eleswhere on this label.

Warnings & Precautions

Source: openFDA

Warnings & Precautions

Warnings For external use only. When using this product skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Pregnancy & Lactation

Lactation

Compatible Hale L1

No information is available on the clinical use of salicylic acid on the skin during breastfeeding.

Chemistry & Properties

2D structure
FormulaC7H6O3
Molecular weight138.12 g/mol
IUPAC name2-hydroxybenzoic acid
CAS69-72-7
PubChem CID338
InChIKeyYGSDEFSMJLZEOE-UHFFFAOYSA-N
logP1.09 (XLogP 2.3)
Polar surface area57.53 Ų
H-bond acceptors / donors2 / 2
Drug-likeness (QED)0.61
Lipinski violations0
SMILESO=C(O)c1ccccc1O

Biology & Pharmacokinetics

Pharmacokinetics

BBB penetrantNo (logBB -1.1)

Enzyme interactions

EnzymeRoleDetail
CYP2C8Inhibitor

Transporters

BCRP (Inhibitor)BCRP (Inhibitor)BSEP (Inhibitor)BSEP (Inhibitor)MATE1 (Inhibitor)MCT (Inhibitor)MCT1 (Inhibitor)MCT4 (Inhibitor)MRP1 (Inhibitor)MRP2 (Inhibitor)MRP4 (Inhibitor)OAT1 (Inhibitor)OAT2 (Inhibitor)OAT3 (Inhibitor)OAT4 (Inhibitor)OATP1B1 (Inhibitor)OATP1B3 (Inhibitor)OCT1 (Inhibitor)OCT2 (Inhibitor)P-gp (Inhibitor)MATE1 (Substrate)MATE2 (Substrate)MCT1 (Substrate)MDR1 (Substrate)MRP2 (Substrate)OATP1B1 (Substrate)OATP1B3 (Substrate)OATP2B1 (Substrate)P-gp (Substrate)

Registered Products (15)

BrandForm / strengthPackAgentCitizen (JOD)
Algesal Baume Cream 6.540 g, 3.460 g 40 g tube pack varies JERASH PHARMACEUTICALS LTD.CO/JORDAN 1.100
Beprosalic Ointment Ointment 0.05 %, 2 % 15 g tube Reda Jardaneh Drug Store 1.310
Pyralvex Solution 1 %, of Rhubarb 5 % 10 ml Khoury Drug Store 2.040
Salibet Ointment Ointment 0.05 %, 3 % 30 g tube شركة مستودع ادوية الايمان 2.280
Salidex Solution Solution 20 mg, 1.2 mg 30 ml PHILADELPHIA PHAEMACEUTICALS.COMP/JORDAN 2.400
Algesal Baume Cream 6.540 g, 3.460 g 100 g tube pack varies JERASH PHARMACEUTICALS LTD.CO/JORDAN 2.600
Emacort Topical Solution Solution 2 %, 0.12 % 30 ml JERASH PHARMACEUTICALS LTD.CO/JORDAN 2.610
psorianol oint Ointment 0.1 %, 1 % 30 g tube MIDDLE EAST PHARMA&CHEMICAL IND/JORDAN 2.880
VERRUMAL Solution Solution 10 %, 0.5 %, 8 g 13 ml Reda Jardaneh Drug Store 3.040
DIPROSALIC Ointment Ointment 0.5 mg, 30 mg/g 30 g tube Adatco Drug Store 3.250
Salicort Oint Ointment 3 %, 0.12 % 30gm Hayat Pharmaceutical Industries CO.PLC/JORDAN 3.460
Salidex Ointment Ointment 3 %, 0.12 % 30 g tube PHILADELPHIA PHAEMACEUTICALS.COMP/JORDAN 3.480
Mobilat-N Cream 0.2 %, 2 % 50gm Salam Drug Store 3.690
Emacort Ointment Ointment 3 %, 1.2 mg/g 30 g tube JERASH PHARMACEUTICALS LTD.CO/JORDAN 3.940
Elicasal Cream 5 % %, 0.1 % 30 gm شركة مستودع ادوية الايمان 5.600